CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Truist Securities Adjusts Gilead Sciences Price Target to $156 From $157

Neutral
AI Analysis

Summary

Truist Securities adjusted its price target for Gilead Sciences slightly downward from $157 to $156 per share.

Importance:1/10
Sentiment:
0.00
analyst_ratingprice_target
Related Companies

Read the original article

Published by yahoo_finance on July 7, 2026 12:55 PM

Read Original